SCHEMBL19920463

SCHEMBL19920463

COc1cc(F)ccc1-c1cccc2cn[nH]c12

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RPS6KA2 Q15349 1/20 0.47
CDK1 P06493 1/20 0.44
CDK9 P50750 1/20 0.44
TRPA1 O75762 1/20 0.43
TRPM8 Q7Z2W7 1/20 0.43
ALDH1A1 P00352 3/20 0.43
KDM4E B2RXH2 2/20 0.43
HPGD P15428 2/20 0.43
HTR2A P28223 1/20 0.42
HTR2C P28335 1/20 0.42
SIRT5 Q9NXA8 1/20 0.42
MAPT P10636 2/20 0.42
MAPK1 P28482 2/20 0.42
POLB P06746 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
RET P07949 1/20 0.41
GAA P10253 2/20 0.41
ALOX15 P16050 1/20 0.41
ALOX12 P18054 1/20 0.41
HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5483794 0.79 HPGD (0.62) RPS6KA2ALDH1A1KDM4EHPGDHTR2A
SCHEMBL3064844 0.75 NOS1 (0.63) RPS6KA2TRPA1ALDH1A1KDM4EHPGD
SCHEMBL18181674 0.71 ALK (0.47) CDK9ALDH1A1KDM4EAMY1A
SCHEMBL31722116 0.68 NOS1 (0.50) TRPA1KDM4EHPGDMAPTNPSR1
SCHEMBL19398634 0.68 ROCK2 (0.59)
SCHEMBL10595701 0.68 ALDH1A1 (0.56) RPS6KA2ALDH1A1KDM4EHPGDHTR2A
SCHEMBL2021959 0.68 KCNH2 (0.40) AMY1A
SCHEMBL10304910 0.68 HTR7 (0.44) CDK1CDK9
SCHEMBL3367775 0.67 NOS1 (0.57) TRPA1TRPM8KDM4EHPGDMAPT
SCHEMBL15624567 0.66 CYP1A1 (0.58) ALDH1A1KDM4EHPGDHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3287463-A1 CONDENSED-RING PYRIMIDYLAMINO DERIVATIVE, PREPARATION METHOD THEREFOR, AND INTERMEDIATE, PHARMACEUTICAL COMPOSITION AND APPLICATIONS THEREOF Guangzhou Maxinovel Pharmaceuticals Co., Ltd. (CN) 2018-02-28 EP disclosed